The draft expert consensus guidance article on managing dupilumab-related ocular surface disorders is now open for consultation. It was jointly produced by the College and the British Association of Dermatologists Dupilumab Ocular Complications Working Group. You can see the Guidance manuscript here and supporting information here. Please forward all comments to [email protected] by Wednesday 6 December.
Have your say on managing dupilumab-related ocular surface disorders guidance
- 17 Nov 2023
- RCOphth